Metformin’s value as a glucose-lowering agent has been established for decades, but does it hold similar promise for reducing rates of cardiovascular disease (CVD)? A
Researchers at the University of Liverpool have found that the weight loss drug, Tirzepatide is associated with significantly reduced risk of developing Type 2 diabetes
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging
Medtronic has announced plans to submit its MiniMed 780G for an expanded indication from the FDA for Type 2 diabetes in the first half of
Trial data has shown that the old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early
An upcoming document by a Lancet Commission of 56 of the world’s leading obesity experts will entirely reframe obesity as a “condition of excess adiposity”
The fifth Sugarplum Dinner, held on Thursday 14 November 2024 and hosted by Jubie Wigan, has raised over £250,000 to help fund global research into
An international study, Colive Voice, presented at the European Association for the Study of Diabetes (EASD) 2024 conference, shows that patients with Type 2 diabetes
A new analysis of real-world data has found that the use of continuous glucose monitoring (CGM) reduces the risk for hospitalization and improves glucose control
Recent research has found that intact fish skin grafts, sourced from Atlantic cod, show superior and faster healing than standard wound care practices in patients with
